Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
about
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cellsThe Warburg effect: 80 years onRelationship Between Dual-Time Point FDG PET and Immunohistochemical Parameters in Preoperative Colorectal Cancer: Preliminary Study.Metabolic genes in cancer: their roles in tumor progression and clinical implicationsUpdate information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomasDefining key signaling nodes and therapeutic biomarkers in NF1-mutant cancers.¹⁸F-fluoro-2-deoxyglucose uptake on PET CT and glucose transporter 1 expression in colorectal adenocarcinoma.Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers.The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas.Prognostic value of 18-fluorodeoxyglucose positron emission tomography-computed tomography in resectable colorectal cancer.The origins of cachexia in acute and chronic inflammatory diseases.Glucose transporter isoform 1 expression enhances metastasis of malignant melanoma cells18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterizationFOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cellsMeta-analysis of histopathological features of primary colorectal cancers that predict lymph node metastases.MicroRNA-218 Increases the Sensitivity of Bladder Cancer to Cisplatin by Targeting Glut1.Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis.Prognostic significance of glucose transporter-1 (GLUT1) gene expression in rectal cancer after preoperative chemoradiotherapy.Immunohistochemical expression of the glucose transporters Glut-1 and Glut-3 in human malignant melanomas and benign melanocytic lesions.Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.Friend or foe? Mitochondria as a pharmacological target in cancer treatment.Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.Preoperative High Maximum Standardized Uptake Value in Association with Glucose Transporter 1 Predicts Poor Prognosis in Pancreatic Cancer.Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.
P2860
Q24648994-3886F95D-A917-4769-996F-E882290550F1Q28076125-1221595F-BCA1-494E-8478-295097B3AD1CQ33704285-89459282-ED9D-4DD9-9301-9B061AFC3A07Q33772469-F4B65235-EA40-458C-B896-71864D1AEE2AQ34204238-298B26D2-BB91-4342-A85D-AB851C410DE9Q34390304-D0A858A3-6A3A-4607-A787-B016820D06EEQ34831255-67B07942-852E-457F-A711-695475B812BEQ35657827-33AA1065-7AFB-494A-87CD-91EDB69C085EQ35670459-B2964CCF-7EC9-4C3F-A913-DD11BF6633F6Q35928789-3C8A2B5A-1C3F-471C-AC78-4E835F2DB27AQ36092014-F6D3C76F-A9DA-4F3D-9207-82EEC13EC229Q36285794-027CA830-830F-4F5C-91F2-03885B1A438AQ36378758-2B454E48-B75C-443D-888E-57235DC56B73Q36544964-22BE86B2-CE8D-4562-A111-8B7164076A22Q37440346-401B7EC7-FC94-47F6-8F0C-4C4FDC9E7E10Q37565352-A3926C47-35DD-49F6-A8E0-B725A2F30375Q37745233-A9C1E4D1-6647-4A15-9DCE-135D97D666B4Q37977032-10C4F4E9-8979-4E1B-9836-47D6556E9BC8Q38715517-02A2A9D1-C55E-4597-93C0-CD99E9650F5AQ38738125-1462E278-3DF7-4991-98F8-3D13CE5776F3Q39445595-25806570-2E81-402A-B084-41C170AA4E19Q41921625-D96FC577-7F04-4243-A801-B0D93641C254Q44205214-985D4836-AAD0-4B85-8698-C9B99D240500Q47357171-A124BD6C-9193-4BB2-8524-9AB9B7841E7FQ48578191-45A1375F-9535-48F0-9093-2FFBF928C44DQ50074585-5AA2DA94-0B1F-4270-BBBA-CC02C5F69DC9Q51144812-0871AF5D-5841-48C3-9722-A03683DBC65FQ54493753-4065987B-D2C0-4813-8B74-2DE3683B6D1C
P2860
Glut1 expression in T1 and T2 stage colorectal carcinomas: its relationship to clinicopathological features.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Glut1 expression in T1 and T2 ...... clinicopathological features.
@ast
Glut1 expression in T1 and T2 ...... clinicopathological features.
@en
type
label
Glut1 expression in T1 and T2 ...... clinicopathological features.
@ast
Glut1 expression in T1 and T2 ...... clinicopathological features.
@en
prefLabel
Glut1 expression in T1 and T2 ...... clinicopathological features.
@ast
Glut1 expression in T1 and T2 ...... clinicopathological features.
@en
P2093
P1476
Glut1 expression in T1 and T2 ...... clinicopathological features.
@en
P2093
Ichihara T
Sakashita M
Shirasaka D
P304
P356
10.1016/S0959-8049(00)00371-3
P577
2001-01-01T00:00:00Z